The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
123461753 12346175 3 F 20160916 20160509 20160923 PER US-PFIZER INC-2016210514 PFIZER 63.00 YR M Y 78.00000 KG 20160923 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
123461753 12346175 1 PS LIPITOR ATORVASTATIN CALCIUM 1 Oral 40 MG, 1X/DAY U 1167724 20702 40 MG FILM-COATED TABLET QD
123461753 12346175 2 SS LIPITOR ATORVASTATIN CALCIUM 1 U 20702 FILM-COATED TABLET
123461753 12346175 3 C CELEXA CITALOPRAM HYDROBROMIDE 1 40 MG, UNK 1166821 0 40 MG TABLET
123461753 12346175 4 C CELEXA CITALOPRAM HYDROBROMIDE 1 Oral 40 MG, DAILY 0 40 MG TABLET
123461753 12346175 5 C LOSARTAN POTASSIUM. LOSARTAN POTASSIUM 1 Oral 100 MG, DAILY 0 100 MG TABLET
123461753 12346175 6 C ATENOLOL. ATENOLOL 1 Oral 25 MG, DAILY 0 25 MG TABLET
123461753 12346175 7 C ALLOPURINOL. ALLOPURINOL 1 Oral 100 MG, DAILY 0 100 MG TABLET
123461753 12346175 8 C CYCLOBENZAPRINE HCL CYCLOBENZAPRINE HYDROCHLORIDE 1 Oral UNK UNK, AS NEEDED (5MG, 1 TO 2 TABLETS, 3 TIMES DAILY) 0 TABLET
123461753 12346175 9 C DICLOFENAC SODIUM. DICLOFENAC SODIUM 1 Transdermal UNK UNK, 2X/DAY 0 GEL BID
123461753 12346175 10 C ELIQUIS APIXABAN 1 Oral 2.5 MG, 2X/DAY (AFTER SURGERY AS DIRECTED) 0 2.5 MG TABLET BID
123461753 12346175 11 C ELIQUIS APIXABAN 1 Oral 5 MG, 2X/DAY 0 5 MG TABLET BID
123461753 12346175 12 C GABAPENTIN. GABAPENTIN 1 Oral 300 MG, 3X/DAY 0 300 MG CAPSULE TID
123461753 12346175 13 C ROBAXIN-750 2 Oral UNK UNK, AS NEEDED (750MG (1 TO 2 TABLETS 3 TIMES DAILY) 0 TABLET
123461753 12346175 14 C TRIAMCINOLONE ACETONIDE. TRIAMCINOLONE ACETONIDE 1 Topical UNK UNK, 2X/DAY (APPLY AND RUB IN A THIN FILM TO AFFECTED AREAS TWICE DAILY) 0 CREAM BID
123461753 12346175 15 C TRIAMCINOLONE ACETONIDE. TRIAMCINOLONE ACETONIDE 1 Nasal UNK UNK, 2X/DAY (55MCG/ACT NASAL AEROSOL, EVERY TWELVE HOUR) 0 NASAL DROPS BID
123461753 12346175 16 C VERAPAMIL HCL VERAPAMIL HYDROCHLORIDE 1 Oral 100 MG, DAILY (BEFORE EATING) 0 100 MG PROLONGED-RELEASE CAPSULE
123461753 12346175 17 C VITAMIN D3 CHOLECALCIFEROL 1 Oral 2000 IU, DAILY 0 2000 IU CAPSULE

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
123461753 12346175 1 Blood cholesterol increased
123461753 12346175 2 Hyperlipidaemia

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
123461753 12346175 Drug ineffective

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
123461753 12346175 1 20060718 0
123461753 12346175 3 20080821 0
123461753 12346175 4 20100607 0
123461753 12346175 5 20111006 0
123461753 12346175 6 20141224 0
123461753 12346175 7 20160720 0
123461753 12346175 8 20160902 0
123461753 12346175 9 20160720 0
123461753 12346175 10 20160822 0
123461753 12346175 11 20160627 0
123461753 12346175 12 20150622 0
123461753 12346175 13 20150729 0
123461753 12346175 14 20160720 0
123461753 12346175 15 20160720 0
123461753 12346175 16 20141212 0
123461753 12346175 17 20101110 0